logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11426388 B1

PDFFull Text
Date of Patent:
Aug. 30, 2022

Filed:

Jul. 02, 2019

Controlled release pharmaceutical formulations of nitazoxanide

Applicant:

Romark Laboratories L. C., Tampa, FL (US);

Inventors:

Jean-Francois Rossignol, St. Petersburg, FL (US);

Marc Ayers, Tampa, FL (US);

Assignee:

Romark Laboratories L.C., Tampa, FL (US);

Attorney:

Foley & Lardner LLP

Primary Examiner:

Johann R Richter

Assistant Examiner:

Danielle Sullivan

Int. Cl.
CPC ...
A61K 31/426 (2006.01); A61K 9/24 (2006.01); A61K 9/28 (2006.01); A61K 31/7056 (2006.01); A61K 38/21 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01);
U.S. Cl.
CPC ...
A61K 31/426 (2013.01); A61K 9/209 (2013.01); A61K 9/2086 (2013.01); A61K 9/28 (2013.01); A61K 9/284 (2013.01); A61K 9/2853 (2013.01); A61K 9/4808 (2013.01); A61K 31/7056 (2013.01); A61K 38/21 (2013.01); A61K 2300/00 (2013.01);
Abstract

Solid dosage formulations of nitazoxanide or a nitazoxanide analogue are provided that comprise a controlled release portion and an immediate release portion. The pharmaceutical composition is typically in the form of a bilayer solid oral dosage form comprising (a) a first layer comprising a first quantity of nitazoxanide or analogue thereof in a controlled release formulation; and (b) a second layer comprising a second quantity of nitazoxanide or analogue thereof in an immediate release formulation. Method of using the formulations in the treatment of hepatitis C are also provided.

Find Patent Forward Citations

Rossignol, Jean-Francois. (2022). Controlled release pharmaceutical formulations of nitazoxanide (U.S. Patent No. 11426388). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11426388

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…